Dyadic International, Inc.
| OTC Markets: DYAI
Dyadic International, Inc. is a biotechnology company, which uses its patented and proprietary technologies to conduct research, development and commercial activities for the discovery, development, manufacture and sale of enzyme and protein products for the bio-energy, industrial enzyme and biopharmaceutical industries. The company operates through two segments: U.S. operations and The Netherlands operations. The U.S. operating segment is a developer, manufacturer and distributor of enzyme products, proteins, peptides and other bio-molecules derived from genes and a collaborative licensor of enabling proprietary and patented technologies for the development and manufacturing of biological products and use in R&D. The Netherlands operating segment is also a developer of enzyme products, proteins, peptides and other bio-molecules derived from genes. Dyadic International was founded by Mark A. Emalfarb in 1979 and is headquartered in Jupiter, FL.